FDA Inspection 1167882 — Soo Aleman, MD
The FDA completed an inspection of Soo Aleman, MD on March 31, 2022 in Stockholm. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 31, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Stockholm (Sweden)
Additional Details
Clinical Investigator (CI)